We are live on ! Find out more
AIM

Aigen Investment Management Portfolio holdings

AUM $389M
1-Year Est. Return 16.77%
This Fund
S&P 500
This Quarter Est. Return
+28.83%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$779M
AUM Growth
+$26.2M
Cap. Flow
-$94.9M
Cap. Flow %
-12.17%
Top 10 Hldgs %
8.33%
Holding
1,483
New
237
Increased
357
Reduced
183
Closed
706

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$5.97M
2
DAL icon
Delta Air Lines
DAL
+$4.91M
3
VRSN icon
VeriSign
VRSN
+$4.72M
4
AWI icon
Armstrong World Industries
AWI
+$3.93M
5
DVN icon
Devon Energy
DVN
+$3.86M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$12.6M
2
MSFT icon
Microsoft
MSFT
+$9.18M
3
DUK icon
Duke Energy
DUK
+$7.4M
4
NUE icon
Nucor
NUE
+$6.45M
5
COST icon
Costco
COST
+$5.74M

Sector Composition

Rank Sector Weight
1 Financials 15.65%
2 Healthcare 15.12%
3 Technology 15.02%
4 Consumer Discretionary 12.92%
5 Industrials 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNV
501
DELISTED
Synovus
SNV
$446K 0.06%
+21,725
New +$420K
IBRX icon
502
ImmunityBio
IBRX
$8.1B
$445K 0.06%
+36,261
New +$205K
CBPO
503
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$442K 0.06%
4,323
-7,673
-64% -$821K
DHC
504
Diversified Healthcare Trust
DHC
$2.14B
$440K 0.06%
+99,424
New +$351K
KB icon
505
KB Financial Group
KB
$43.5B
$436K 0.06%
15,661
+14,124
+919% +$386K
NBIX icon
506
Neurocrine Biosciences
NBIX
$16.6B
$436K 0.06%
3,575
-4,349
-55% -$481K
OXFD
507
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$436K 0.06%
+33,550
New +$403K
NVAX icon
508
Novavax
NVAX
$1.31B
$435K 0.06%
+5,213
New +$199K
LPLA icon
509
LPL Financial
LPLA
$28.6B
$434K 0.06%
5,541
+221
+4% +$14.8K
MNRO icon
510
Monro
MNRO
$398M
$434K 0.06%
7,891
-1,779
-18% -$94.7K
TARO
511
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$434K 0.06%
6,522
+3,334
+105% +$224K
AHRT
512
AH Realty Trust
AHRT
$517M
$431K 0.06%
43,291
+23,531
+119% +$213K
FTCH
513
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$427K 0.05%
24,712
-10,211
-29% -$139K
BOKF icon
514
BOK Financial
BOKF
$8.74B
$425K 0.05%
7,536
-11,388
-60% -$583K
CLS icon
515
Celestica
CLS
$36.5B
$423K 0.05%
61,920
-61,513
-50% -$352K
MGEE icon
516
MGE Energy Inc
MGEE
$3.08B
$423K 0.05%
6,556
-559
-8% -$36.5K
VPG icon
517
Vishay Precision Group
VPG
$914M
$416K 0.05%
16,927
+13,790
+440% +$310K
VRRM icon
518
Verra Mobility
VRRM
$744M
$416K 0.05%
40,481
-43,363
-52% -$411K
EYE icon
519
National Vision
EYE
$1.81B
$415K 0.05%
13,589
+10,939
+413% +$287K
TMX
520
DELISTED
Terminix Global Holdings, Inc.
TMX
$414K 0.05%
11,609
+11,316
+3,862% +$349K
NEOG icon
521
Neogen
NEOG
$2.5B
$413K 0.05%
10,634
+4,386
+70% +$148K
EHC icon
522
Encompass Health
EHC
$12.4B
$411K 0.05%
+8,335
New +$450K
FVRR icon
523
Fiverr
FVRR
$339M
$411K 0.05%
5,561
+2,165
+64% +$111K
GAIN icon
524
Gladstone Investment Corp
GAIN
$661M
$409K 0.05%
39,900
+6,466
+19% +$66.4K
FBK icon
525
FB Financial Corp
FBK
$3.04B
$406K 0.05%
16,381
-2,343
-13% -$52.2K
19 20
21
22 23

Similar funds

SA
Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
SI
Schusterman Interests Tulsa, Oklahoma $391M AUM 33.81% 1-Year Est. Return
MA
Mezzasalma Advisors Tinton Falls, New Jersey $391M AUM 40.85% 1-Year Est. Return
TCM
Turas Capital Management Boston, Massachusetts $392M AUM
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Aigen Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Aigen Investment Management held 1,483 positions worth $779M, up 3.5% from $753M the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

Aigen Investment Management withdrew a net $94.9M in Q2 2020, closing 706 positions and reducing 183 holdings. Its most notable exit was Microsoft, an estimated $9.18M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Aigen Investment Management opened a new position in Berkshire Hathaway Class B worth $5.84M.

  • Aigen Investment Management's largest Q2 2020 buy was Berkshire Hathaway Class B: 32,702 shares worth $5.84M.
  • Aigen Investment Management added most to Delta Air Lines in Q2 2020, an estimated $4.91M increase.
  • Aigen Investment Management's biggest Q2 2020 reduction was Thermo Fisher Scientific, cutting an estimated $12.6M.
  • Aigen Investment Management fully exited Microsoft in Q2 2020, selling an estimated $9.18M.
  • Aigen Investment Management's ten largest holdings make up 8.3% of its $779M portfolio in Q2 2020.
  • Aigen Investment Management opened 237 new positions and closed 706 in Q2 2020.
  • Aigen Investment Management's portfolio value rose 3.5% quarter-over-quarter to $779M.

Based on Aigen Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.